Long noncoding RNAs (lncRNAs) are recently implicated in modifying immunology in
colorectal cancer (CRC). Nevertheless, the clinical significance of immune-related lncRNAs …

Infection susceptibility, poor vaccination efficacy, age-related disease onset, and neoplasms
are linked to innate and adaptive immune dysfunction that accompanies aging (known as …

Despite centuries since the discovery and study of cancer, cancer is still a lethal and
intractable health issue worldwide. Cancer-associated fibroblasts (CAFs) have gained much …

The discovery of immune checkpoint inhibitors (ICIs) has now been universally acknowledged
as a significant breakthrough in tumor therapy after the targeted treatment of checkpoint …

The cascade of metastasis in tumor cells, exhibiting organ-specific tendencies, may occur at
numerous phases of the disease and progress under intense evolutionary pressures. Organ-…

Background Long non-coding RNAs (lncRNAs) have recently emerged as essential biomarkers
of cancer progression. However, studies are limited regarding lncRNAs correlated with …

Long noncoding ribonucleic acids (RNAs; lncRNAs) have been associated with cancer
immunity regulation. However, the roles of immune cell-specific lncRNAs in glioblastoma (GBM) …

The term ferroptosis was put forward in 2012 and has been researched exponentially over
the past few years. Ferroptosis is an unconventional pattern of iron-dependent programmed …

Cancer drug resistance represents the main obstacle in cancer treatment. Drug-resistant
cancers exhibit complex molecular mechanisms to hit back therapy under pharmacological …

Chimeric antigen receptor (CAR)-T cell therapy represents a landmark advance in personalized
cancer treatment. CAR-T strategy generally engineers T cells from a specific patient with …